Felycin-CA1 (sirolimus delayed-release tablets), 2.4 mg per tablet

Supplied By: PRN Pharmacal (30091893)


SKU
085235


Unit of
Measure 12 Count


Pack
Type Box


Case
Qty 32

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Jul- 2025 Jun- 2025 May- 2025 Apr- 2025 Mar- 2025 Feb- 2025 Jan- 2025 Dec- 2024 Nov- 2024 Oct- 2024 Sep- 2024 Aug- 2024 Jul- 2024
{{purchaseHistoryItem}}


SKU 085235


Size 12 Count

Case
Qty 32

Purchase History

Jul- 2025 {{productPurchaseHistory['085235'][0]}} Dec- 2024 {{productPurchaseHistory['085235'][0+7]}}
Jun- 2025 {{productPurchaseHistory['085235'][1]}} Nov- 2024 {{productPurchaseHistory['085235'][1+7]}}
May- 2025 {{productPurchaseHistory['085235'][2]}} Oct- 2024 {{productPurchaseHistory['085235'][2+7]}}
Apr- 2025 {{productPurchaseHistory['085235'][3]}} Sep- 2024 {{productPurchaseHistory['085235'][3+7]}}
Mar- 2025 {{productPurchaseHistory['085235'][4]}} Aug- 2024 {{productPurchaseHistory['085235'][4+7]}}
Feb- 2025 {{productPurchaseHistory['085235'][5]}} Jul- 2024 {{productPurchaseHistory['085235'][5+7]}}
Jan- 2025 {{productPurchaseHistory['085235'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Felycin®-CA1 is a once-weekly tablet indicated for the management of ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy (HCM).

Features & Benefits

  • The first FDA conditionally-approved drug for the management of ventricular hypertrophy in cats with subclinical HCM
  • Available in three strengths
  • Weight-band dosing ensure accurate administration for maximum therapeutic efficacy